Loading organizations...
§ Private Profile · Harwell, Oxfordshire, United Kingdom
Biotechnology company developing therapeutics for mitochondrial dysfunction
MitoRx Therapeutics has raised $12.3M across 2 funding rounds.
MitoRx Therapeutics has raised $12.3M in total across 2 funding rounds.
MitoRx Therapeutics has raised $12.3M across 2 funding rounds. Most recently, it raised $7.3M Pre-Series A in December 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 1, 2025 | $7.3M Seed Plus | Justin Cahill | — | Announced |
| Dec 18, 2023 | $5.1M Seed | — | Fink Family Office, Longevity Tech Fund, Oxford Technology Management, Science Angel Syndicate, Oliver Sexton, Wren Capital | Announced |
MitoRx Therapeutics has raised $12.3M in total across 2 funding rounds.
MitoRx Therapeutics's investors include Justin Cahill, Fink Family Office, Longevity Tech Fund, Oxford Technology Management, Science Angel Syndicate, Oliver Sexton, Wren Capital.